中国肝脏病杂志(电子版)
中國肝髒病雜誌(電子版)
중국간장병잡지(전자판)
CHINESE JOURNAL OF LIVER DISEASES(ELECTRONIC VERSION)
2014年
3期
44-46
,共3页
肝硬化%胃肠出血%凝血酶
肝硬化%胃腸齣血%凝血酶
간경화%위장출혈%응혈매
Liver cirrhosis%Gastrointestinal hemorrhage%Thrombin
目的:分析肝硬化合并上消化道出血联合使用不同止血药物的疗效。方法选择2010年11月至2013年11月铁岭市中心医院肝硬化合并上消化道出血患者304例,随机分为治疗组152例与对照组152例,两组患者均采用内科消化道出血常规治疗(包括抗感染、补液、保肝及心理治疗)。治疗组患者在此基础上加用注射用奥曲肽、注射用氨甲环酸、注射用蛇毒血凝酶、注射用泮托拉唑等静脉输注止血、对症治疗;对照组加用注射用奥曲肽、注射用奥美拉唑、注射用止血芳酸静脉输注,注射用维生素K及注射用肾上腺色腙肌注,凝血酶冻干粉口服等止血对症治疗。结果治疗组总有效率为98.68%,对照组为86.84%,两组差异有统计学意义(P =0.0001)。结论内科药物经验性的综合应用能够有效治疗肝硬化合并上消化道出血,提高治愈率,减少病死率,经济高效,值得临床推广。
目的:分析肝硬化閤併上消化道齣血聯閤使用不同止血藥物的療效。方法選擇2010年11月至2013年11月鐵嶺市中心醫院肝硬化閤併上消化道齣血患者304例,隨機分為治療組152例與對照組152例,兩組患者均採用內科消化道齣血常規治療(包括抗感染、補液、保肝及心理治療)。治療組患者在此基礎上加用註射用奧麯肽、註射用氨甲環痠、註射用蛇毒血凝酶、註射用泮託拉唑等靜脈輸註止血、對癥治療;對照組加用註射用奧麯肽、註射用奧美拉唑、註射用止血芳痠靜脈輸註,註射用維生素K及註射用腎上腺色腙肌註,凝血酶凍榦粉口服等止血對癥治療。結果治療組總有效率為98.68%,對照組為86.84%,兩組差異有統計學意義(P =0.0001)。結論內科藥物經驗性的綜閤應用能夠有效治療肝硬化閤併上消化道齣血,提高治愈率,減少病死率,經濟高效,值得臨床推廣。
목적:분석간경화합병상소화도출혈연합사용불동지혈약물적료효。방법선택2010년11월지2013년11월철령시중심의원간경화합병상소화도출혈환자304례,수궤분위치료조152례여대조조152례,량조환자균채용내과소화도출혈상규치료(포괄항감염、보액、보간급심리치료)。치료조환자재차기출상가용주사용오곡태、주사용안갑배산、주사용사독혈응매、주사용반탁랍서등정맥수주지혈、대증치료;대조조가용주사용오곡태、주사용오미랍서、주사용지혈방산정맥수주,주사용유생소K급주사용신상선색종기주,응혈매동간분구복등지혈대증치료。결과치료조총유효솔위98.68%,대조조위86.84%,량조차이유통계학의의(P =0.0001)。결론내과약물경험성적종합응용능구유효치료간경화합병상소화도출혈,제고치유솔,감소병사솔,경제고효,치득림상추엄。
Objective To analyze the effect of combined using different hemostatic drugs to treat liver cirrhosis with upper gastrointestinal hemorrhage. Methods From November 2010 to November 2013, 304 patients of liver cirrhosis with upper gastrointestinal hemorrhage were randomly divided into treatment group (152 cases) and control group (152 cases). Two groups were given medical conventional treatment of gastrointestinal bleeding (including resistance to infection, fluid infusion, protecting liver and psychotherapy). On this basis, the treatment group was given octreotide, tranexamic acid, hemocoagulase and pantoprazole intravenous drip to stop bleeding and expectant treatment. And the control group was given octreotide, omeprazole and p-aminomethyl benzoic acid intravenous drip, vitamin K and adrenochrome semicarbazone intramuscular injection, and lyophilizing thrombin powder oral for hemostasis treatment. Results Total effective rate of treatment group was 98.68% and control group was 86.84%, two groups showed statistically significant (P= 0.0001). Conclusions Internal medicine empirical comprehensive application can effectively treat liver cirrhosis with upper gastrointestinal hemorrhage, improve the cure rate, reduce mortality, economic efficiency, worth clinical promotion.